Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel N Wolfe

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Microorganisms|May 6, 2020
Current State of Anthrax Vaccines and Key R&D Gaps Moving ForwardAdam Clark, Daniel N Wolfe
Frontiers in Microbiology|January 8, 2015
Vaccination against Q fever for biodefense and public health indicationsSara Ruiz, Daniel N Wolfe
Methods in Molecular Biology (Clifton, N.J.)|November 25, 2024
Marburg Virus Medical CountermeasuresKaren A Martins, Daniel N Wolfe
Human Vaccines & Immunotherapeutics|February 23, 2013
Current biodefense vaccine programs and challengesDaniel N Wolfe, William Florence, Paula Bryant
Vaccines|March 26, 2022
Utilization of Viral Vector Vaccines in Preparing for Future PandemicsKimberly A Hofmeyer, Katherine M Bianchi, Daniel N Wolfe
Plos One|January 27, 2009
Inefficient Toll-like receptor-4 stimulation enables Bordetella parapertussis to avoid host immunityDaniel N Wolfe, Anne M Buboltz, Eric T Harvill
The New England Journal of Medicine|July 15, 2024
Anticipating the Next PandemicH Cody Meissner, Bill G Kapogiannis, Daniel N Wolfe
Human Vaccines & Immunotherapeutics|April 11, 2020
Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virusDaniel N Wolfe, Marva J Taylor, Amanda G Zarrabian
Infection and Immunity|September 24, 2005
Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunityDaniel N Wolfe, Girish S Kirimanjeswara, Eric T Harvill
Human Vaccines & Immunotherapeutics|December 12, 2025
Viral correlates of protection and the multifarious interactions of B and T cellsH Cody Meissner, Peter B Gilbert, Derek Eisnor, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Microorganisms|May 6, 2020
Current State of Anthrax Vaccines and Key R&D Gaps Moving ForwardAdam Clark, Daniel N Wolfe
Frontiers in Microbiology|January 8, 2015
Vaccination against Q fever for biodefense and public health indicationsSara Ruiz, Daniel N Wolfe
Methods in Molecular Biology (Clifton, N.J.)|November 25, 2024
Marburg Virus Medical CountermeasuresKaren A Martins, Daniel N Wolfe
Human Vaccines & Immunotherapeutics|February 23, 2013
Current biodefense vaccine programs and challengesDaniel N Wolfe, William Florence, Paula Bryant
Vaccines|March 26, 2022
Utilization of Viral Vector Vaccines in Preparing for Future PandemicsKimberly A Hofmeyer, Katherine M Bianchi, Daniel N Wolfe
Plos One|January 27, 2009
Inefficient Toll-like receptor-4 stimulation enables Bordetella parapertussis to avoid host immunityDaniel N Wolfe, Anne M Buboltz, Eric T Harvill
The New England Journal of Medicine|July 15, 2024
Anticipating the Next PandemicH Cody Meissner, Bill G Kapogiannis, Daniel N Wolfe
Human Vaccines & Immunotherapeutics|April 11, 2020
Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virusDaniel N Wolfe, Marva J Taylor, Amanda G Zarrabian
Infection and Immunity|September 24, 2005
Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunityDaniel N Wolfe, Girish S Kirimanjeswara, Eric T Harvill
Human Vaccines & Immunotherapeutics|December 12, 2025
Viral correlates of protection and the multifarious interactions of B and T cellsH Cody Meissner, Peter B Gilbert, Derek Eisnor, et al.
Pageof 4